ANALYZING THE CORRELATION OF BIOCHEMICAL AND PERCEIVED HYPOGONADISM IN DIABETIC MEN: A PILOT SURVEY AT LADY READING HOSPITAL
Main Article Content
Keywords
Hypogonadism, testosterone, diabetic subjects, perceived pathology, biochemical test, man health status
Abstract
Background: Diabetes mellitus is a prime endocrine disorder that lowers sexual hormone levels, mainly testosterone, resulting in hypogonadism in affected males. It may be concluded that a clear comprehension of the relationship between biochemical and perceived hypogonadism is essential to enhance the utilization of specialized services for this population.
Objective: To investigate a linear relationship between biochemical hypogonadism, specifically serum testosterone levels, and perceived hypogonadal symptoms in men with diabetes.
Methodology: Analyzed cross-sectionally at Lady Reading Hospital over six months, the study enrolled 254 diabetic men. Biochemical hypogonadism was operationalized as total testosterone below 300 ng/dL while perceived hypogonadism was measured using the Androgen Deficiency in the Aging Male (AMS) score. Descriptive statistics were used to measure the frequencies of biochemical and perceived hypogonadism and their relationship.
Results: Out of 1155 men, 226 (88.2%) had biochemical hypogonadism, and 163 (63.6%) had perceived hypogonadal symptoms. A statistically seasonal significant difference was observed in self-perceived hypogonadism between the two groups In this study, 70 out of the 128 participants with biochemical hypogonadism complained of symptoms of hypogonadism with only 24 out of the 121 participants with normal testosterone scores reporting symptoms of hypogonadism (p < 0.001).
Conclusion: The present work emphasizes the frequency of biochemical and/or perceived hypogonadism in diabetic men and calls for regular screening for hypogonadism. An association between hormonal imbalance and lower quality of life and health was seen in this sample of this population, managing these hormonal imbalances might enhance quality of life and overall health.
References
2. Alvarez-Payares JC, Bello-Simanca JD, De La Peña-Arrieta EDJ, Agamez-Gomez JE, Garcia-Rueda JE, Rodriguez-Arrieta A, et al. Common pitfalls in the interpretation of endocrine tests. Frontiers in Endocrinology. 2021;12:727628.
3. Gianatti E, Grossmann M. Testosterone deficiency in men with Type 2 diabetes: pathophysiology and treatment. Diabetic Medicine. 2020;37(2):174-86.
4. Ozgurtas EM, Ozgurtas T. Biochemical Analysis and Laboratory Tests in Andrology and Sexual Medicine. Andrology and Sexual Medicine: Springer; 2022. p. 433-45.
5. Al-Sharefi A, Quinton R. Current national and international guidelines for the management of male hypogonadism: helping clinicians to navigate variation in diagnostic criteria and treatment recommendations. Endocrinology and Metabolism. 2020;35(3):526-40.
6. Swislocki AL, Eisenberg ML. A Review on Testosterone: Estradiol Ratio—Does It Matter, How Do You Measure It, and Can You Optimize It? The World Journal of Men's Health. 2024;42.
7. Louters M, Pearlman M, Solsrud E, Pearlman A. Functional hypogonadism among patients with obesity, diabetes, and metabolic syndrome. International journal of impotence research. 2022;34(7):714-20.
8. He Z, Yin G, Li QQ, Zeng Q, Duan J. Diabetes mellitus causes male reproductive dysfunction: A review of the evidence and mechanisms. in vivo. 2021;35(5):2503-11.
9. Salah M, Ismail KA, Khadrawy SM. Nobiletin protects against diabetes-induced testicular injury via hypophysis–gonadal axis upregulation and amelioration of oxidative stress. Molecular Biology Reports. 2022:1-15.
10. Maiorino MI, Bellastella G, Esposito K. Diabetes and sexual disorders. Diabetes Complications, Comorbidities and Related Disorders. 2020:473-94.
11. Vickers AJ, Tin AL, Singh K, Dunn RL, Mulhall J. Updating the international index of erectile function: evaluation of a large clinical data set. The journal of sexual medicine. 2020;17(1):126-32.
12. Erenpreiss J, Fodina V, Pozarska R, Zubkova K, Dudorova A, Pozarskis A. Prevalence of testosterone deficiency among aging men with and without morbidities. The Aging Male. 2020.
13. Kumari N, Khan A, Shaikh U, Lobes K, Kumar D, Suman F, et al. Comparison of testosterone levels in patients with and without type 2 diabetes. Cureus. 2021;13(7).
14. Hackett G, Kirby M, Rees RW, Jones TH, Muneer A, Livingston M, et al. The British Society for Sexual Medicine guidelines on male adult testosterone deficiency, with statements for practice. The world journal of men's health. 2023;41(3):508.
15. Liang G, Song Y, Liu L, Zhou K, Tian J, Li J, et al. Association of hypogonadism symptoms and serum hormones in aging males. Andrologia. 2021;53(5):e14013.
16. Boeri L, Capogrosso P, Ventimiglia E, Schifano N, Montanari E, Montorsi F, et al. Sexual dysfunction in men with prediabetes. Sexual medicine reviews. 2020;8(4):622-34.
17. Yannas D, Frizza F, Vignozzi L, Corona G, Maggi M, Rastrelli G. Erectile dysfunction is a hallmark of cardiovascular disease: unavoidable matter of fact or opportunity to improve men’s health? Journal of Clinical Medicine. 2021;10(10):2221.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Dr. Shahid Shehzad
Assistant Professor Endocrinology, Department of Diabetes and Endocrinology, Mercy Teaching Hospital, Peshawar
Dr. Faheem Ullah
Assistant Professor Endocrinology, Department of Endocrinology and Diabetes Mercy Teaching Hospital, Peshawar
Dr. Asad Ullah
Assistant Professor Endocrinology, Division of Endocrinology, Department of Medicine
Dr Ambreen Gul
Associate Professor Chemical Pathology, Peshawar Medical College. Riphah International University, Islamabad